0000950170-24-014006.txt : 20240212
0000950170-24-014006.hdr.sgml : 20240212
20240212180225
ACCESSION NUMBER: 0000950170-24-014006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldshleger Ilya
CENTRAL INDEX KEY: 0001874147
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40690
FILM NUMBER: 24621742
MAIL ADDRESS:
STREET 1: C/O RXSIGHT, INC.
STREET 2: 100 COLUMBIA
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RxSight, Inc.
CENTRAL INDEX KEY: 0001111485
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943268801
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 COLUMBIA STREET
STREET 2: SUITE 120
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
BUSINESS PHONE: 949-521-7822
MAIL ADDRESS:
STREET 1: 100 COLUMBIA STREET
STREET 2: SUITE 120
CITY: ALISO VIEJO
STATE: CA
ZIP: 92656
FORMER COMPANY:
FORMER CONFORMED NAME: CALHOUN VISION INC
DATE OF NAME CHANGE: 20000410
4
1
ownership.xml
4
X0508
4
2024-02-09
0001111485
RxSight, Inc.
RXST
0001874147
Goldshleger Ilya
C/O RXSIGHT, INC.
100 COLUMBIA
ALISO VIEJO
CA
92656
false
true
false
false
Chief Operating Officer
true
Common Stock
2024-02-09
4
M
false
5365
18.90
A
31840
D
Common Stock
2024-02-09
4
M
false
5000
23.04
A
36840
D
Common Stock
2024-02-09
4
S
false
5365
50.5012
D
31475
D
Common Stock
2024-02-09
4
S
false
5000
51
D
26475
D
Common Stock
1372
I
By spouse
Stock Option (right to buy)
18.90
2024-02-09
4
M
false
5365
0.00
D
2022-07-26
2028-07-25
Common Stock
5365
3995
D
Stock Option (right to buy)
23.04
2024-02-09
4
M
false
5000
0.00
D
2021-04-18
2029-04-17
Common Stock
5000
25000
D
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2023 by the Reporting Person.
Represents the weighted average share price of an aggregate total of 5,365 shares sold in the price range of $50.50 to $50.54 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Shelley Thunen, as Attorney-in-Fact
2024-02-12